Company Filing History:
Years Active: 2021
Title: Michelle Fleury: Innovator in Drug Responsive Domains
Introduction
Michelle Fleury is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of drug responsive domains. Her innovative work focuses on enhancing the stability of therapeutic proteins, which has important implications for medical treatments.
Latest Patents
Michelle Fleury holds a patent for her invention titled "CA2 compositions and methods for tunable regulation." This patent describes drug responsive domains derived from human carbonic anhydrase 2 that can modulate protein stability for human interleukin 15 (IL15) payloads. The compositions and methods outlined in her patent offer new avenues for therapeutic applications.
Career Highlights
Currently, Michelle Fleury is associated with Obsidian Therapeutics, Inc., where she continues to advance her research and development efforts. Her work at Obsidian Therapeutics focuses on innovative solutions in the biotechnology sector, contributing to the company's mission of creating transformative medicines.
Collaborations
Throughout her career, Michelle has collaborated with talented individuals such as Kutlu Goksu Elpek and Dhruv Kam Sethi. These collaborations have fostered a dynamic environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Michelle Fleury is a trailblazer in the biotechnology industry, with her patent and work at Obsidian Therapeutics showcasing her commitment to innovation. Her contributions are paving the way for future advancements in drug development and therapeutic applications.